| 中文名称 | 人参皂苷Rh2 |
|---|---|
| 中文别名 | 人参皂苷 Rh2;人参皂苷-RH2;(R型)人参皂苷RH2;人参皂荚RH2;人参皂苷 S-RH2;人参皂苷RH2(标准品);人参皂甙 Rh2;(20S)人参皂苷 Rh2;(S型)人参皂苷Rh2;20(S)-人参皂苷Rh2;20(S)-人参皂苷-RH2;20(S)-人参皂苷-RH2,20(S)-Ginsenoside-RH2,植物提取物,标准品,对照品;S-人参皂苷Rh2;人参皂甙 Rh2 Ginsenoside Rh2;人参皂苷 Rh2 (S-FORM)(AS);人参皂苷 Rh2 (S-FORM)(P);人参皂苷Rh2 对照品标准品;人参皂苷Rh2 标准品;人参皂苷Rh2(S);人参皂苷Rh2(人参皂苷S- Rh2 、20(S)-人参皂苷RH2);人参皂苷Rh2对照品;分析对照品;人参皂苷Rh2(对照品) |
| 英文名称 | Ginsenoside Rh2 |
| 英文别名 | Ginsenoside Rh2;(3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl beta-d-glucopyranoside;dihydroxydammar-24-en-3-yl;β-D-Glucopyranoside, (3β,12β)-12,20-;R-form-Ginsenoside Rh2;12β,20-Dihydroxy-5α-dammar-24-en-3β-yl β-D-glucopyranoside;3β-(β-D-Glucopyranosyloxy)dammara-24-ene-12β,20-diol;20(S)-Ginsenoside Rh2;20-(S)-GinsenosideRh2;GINSENOSIDE Rh2 (S-FORM)(AS) PrintBack;(3β,12β)-12,20-Dihydroxydammar-24-en-3-yl-β-D-glucopyranoside;20(S)-Rh2;ginenoside Rh2;Ginsenoside-Rh2;20(S)-Ginsenoside-Rh2;2-[[(8R,10R,14R)-12-Hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5;(20S)-ginsenoside Rh2;3-O-.BETA.-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL;s9023;Ginsenoside Rh2; 20(s)-Ginsenoside Rh2;C22128;(S)-(3b,12b)-12,20-Dihydroxydammar-24-en-3-yl beta-D-glucopyranoside;BDBM50023457;0JU44A5KWG;CS-3835;78214-33-2;MFCD00800712;AC-33940;Q27146703;20S-protopanaxdiol-3-O-beta-D- glucopyranoside;GinsenosideRh2;CCG-270259;Q-100827;20S-GinsenosideRh2;3beta-(beta-D-glucopyranosyloxy)dammar-24-ene-3beta,20beta-diol;20(S)-Ginsenoside;GINSENOSIDE 20-RH2;67400-17-3;.BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,12.BETA.)-12,20-DIHYDROXYDAMMAR-24-EN-3-YL;beta-D-Glucopyranoside, (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl;UNII-0JU44A5KWG;CHEMBL1783834;DTXSID70999457;(20R)Ginsenoside Rh2;CHEBI:77147;SCHEMBL24209709;Ginsenoside Rh2, analytical standard;AKOS037514675;112246-15-8;(20R)-Ginsenoside Rh2;GINSENOSIDE RH2(S);20S-Ginsenoside Rh2;CCG-270261;(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;HY-N0605;s9036;1ST156862;20(S)- Ginsenoside Rh2;CHEBI:172776;2-[[12-hydroxy-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;3-O-(c)micro-D-Glucopyranoside pound>>(R)Ginsenoside-Rh2 pound>>20(R)-Ginsenoside;20(R)-Ginsenoside Rh2;LS-15384;SY105541;20(S)-Ginsenoside Rh2; 20(S)-Rh2; Ginsenoside-Rh2;A839365;MFCD22200425;BCP23574;2-(hydroxymethyl)-6-[[4,4,8,10,14-pentamethyl-17-(6-methyl-2-oxidanyl-hept-5-en-2-yl)-12-oxidanyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol;(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;BCP10285;Ginsenoside Rh2 (S-FORM) |
| CAS No. | 78214-33-2 |
| 分子式 | C36H62O8 |
| 分子量 | 622.87 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学